the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Red Bull have taken 220 staff from Mercedes, says Horner

RED BULL boss Christian Horner has responded to claims staff were increasingly looking to leave his team by saying the Formula One champions have so far taken 220 from rivals Mercedes.

Dominant Red Bull have been unsettled by allegations against Horner of misconduct towards a female employee, which the boss has denied and been cleared of.

Star designer Adrian Newey has announced he is leaving next year and McLaren boss Zak Brown told reporters at the weekend’s Miami Grand Prix that resumes were flying around and Newey was the first domino to fall.

Mercedes boss Toto Wolff, who has been making overtures to Red Bull’s triple world champion Max Verstappen with Ferrari-bound Lewis Hamilton’s seat to fill, said his team had “seen Red Bull CVs through all of the levels.”

ALSO READ: F1 world champion Verstappen commits to Red Bull

Horner told reporters after Sunday’s race, with McLaren’s Lando Norris taking his first win, that there would always be movement between teams.

“I don’t know how many people we’ve employed from McLaren this year or how many people VCARB (Red Bull’s RB sister team) have employed (from) Mercedes,“ he added.

“We’ve taken 220 people, 220 out of HPP (Mercedes AMG’s High Performance Powertrains) into Red Bull Powertrains, so when we’re talking of losing people, I’d be a bit more worried about the 220 than maybe one or two CVs.”

Red Bull are building their own powertrain for 2026, when the sport undergoes a major engine rule change, with a major expansion at their Milton Keynes facility.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings